Gastrointestinal Cancer
From the Journals
Biomarkers in saliva may detect hepatocellular carcinoma
MicroRNA biomarkers may provide a means of accurately and remotely testing for this increasingly common cancer, according to a small pilot study’s...
From the Journals
Spanish-speaking navigators show Hispanic patients path to CRC screening
An outreach effort in Rhode Island boosted rates of colonoscopy well above the national benchmark.
Latest News
ctDNA identifies CRC patients who benefit from adjuvant therapy
The study shows that stratifying postsurgical treatment decisions using the assay can identify patients likely to benefit from adjuvant...
Latest News
Dual immunotherapy promising new option for liver cancer
The novel regimen, dubbed STRIDE, comprised a single priming dose of the investigational agent tremelimumab followed by regular doses of...
From the Journals
Primer message boosts colorectal cancer screening rates
Sending adults an electronic notification prior to mailing a fecal immunochemical test improves rates of test completion.
Latest News
Adding TACE to lenvatinib improves survival in liver cancer
The combination of TACE and lenvatinib "represents a potential new first-line treatment option for patients with advanced HCC."
From the Journals
Improved follow-up needed to find late-stage pancreatic cancers
Factors associated with detecting late-stage pancreatic ductal adenocarcinomas during this follow-up are hard to pin down.
From the Journals
Early-onset colorectal cancer in young patients is rising, often advanced at diagnosis
Long delays between symptom onset and cancer diagnosis in young patients can increase the chance of younger patients presenting with distant-stage...
Diminutio
“I didn’t want to meet you.” Dispelling myths about palliative care
This is the first installment of “Diminutio,” a column by Sarah D’Ambruoso, NP, a palliative care nurse in oncology. Today, she shares stories...
Latest News
Confirmed: Pembro plus chemo as first-line standard of care for esophageal cancer
An interim analysis of KEYNOTE-590 found that the combination of pembrolizumab and chemotherapy as first-line treatment, proved superior to...
From the Journals
Potential new standard of care for biliary tract cancer
Biliary tract cancers are a relatively rare and heterogeneous group of cancers, but global incidence is rising.